Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03855878 · ClinicalTrials.gov registry record

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

A clinical trial, sponsored by Indiana University.

Completed
Registry status
209
Enrollment target

NCT03855878: Completed study, sponsored by Indiana University.

NCT03855878 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03855878 has completed, sponsored by Indiana University.

COMPLETED
Registry status
209 participants
Enrollment target

Study Summary

Screening study to determine incidence of MGUS in this patient population

Primary Outcome

The primary analysis focuses on the estimation of the rate of MGUS for this specific population.

Trial Details

FieldValue
Enrollment Target 209 participants
Start Date 2018-12-10
Est. Completion 2024-09-12
Indiana University

890 total trials

What the finished NCT03855878 record still lists

NCT03855878 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT03855878 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03855878 about?

NCT03855878 is a clinical study titled "Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery". Screening study to determine incidence of MGUS in this patient population

What is the current status of trial NCT03855878?

This trial is currently completed. The enrollment target is 209 participants. The study started on 2018-12-10. Estimated completion is 2024-09-12.

Who is sponsoring clinical trial NCT03855878?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04742634 · 209 participants · Phase 1

    Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

  • NCT07214688 · 209 participants · Phase 2

    Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03855878, the US trial registry maintained by the National Library of Medicine. NCT03855878 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.